VAERS reports by lot

Novartis Vaccines Meningococcal lot ABXA93AA: VAERS reports

20 VAERS reports list lot ABXA93AA as a Novartis Vaccines Meningococcal vaccine, received between 2020-08-13 and 2022-04-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1630%
General / Systemic (non-local)1121%
Neurological59%
Musculoskeletal59%
Dermatological (non-injection-site)59%
Allergic / Anaphylactic48%
Gastrointestinal48%
Cardiac / Cardiovascular36%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois3
California2
Georgia2
Iowa2
Utah1
Kentucky1
Arkansas1
Nebraska1
North Dakota1
North Carolina1
Arizona1
Indiana1

Reports by month received

2020-082
2020-093
2020-102
2020-112
2020-121
2021-013
2021-052
2021-083
2022-031
2022-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.